RPS6KB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.547400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.609200E-01
Normal-vs-Stage2
4.887000E-01
Normal-vs-Stage3
4.594000E-02
Normal-vs-Stage4
3.713200E-01
Stage1-vs-Stage2
8.268400E-01
Stage1-vs-Stage3
1.804960E-01
Stage1-vs-Stage4
7.581800E-01
Stage2-vs-Stage3
1.173440E-01
Stage2-vs-Stage4
5.805400E-01
Stage3-vs-Stage4
3.385200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.212600E-01
Normal-vs-AfricanAmerican
7.594200E-01
Normal-vs-Asian
5.620600E-01
Caucasian-vs-AfricanAmerican
5.205200E-01
Caucasian-vs-Asian
8.431200E-01
AfricanAmerican-vs-Asian
6.981400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.253600E-01
Normal-vs-Female
5.174400E-01
Male-vs-Female
3.518800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.483200E-01
Normal-vs-Age(41-60Yrs)
9.431600E-01
Normal-vs-Age(61-80Yrs)
3.021000E-01
Normal-vs-Age(81-100Yrs)
6.591800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.849400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.068400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.293200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.117690E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.143920E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.606000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.562300E-02
Normal-vs-Daily Drinker
1.351770E-01
Normal-vs-Weekly Drinker
2.884200E-01
Normal-vs-Occasional Drinker
8.859000E-01
Normal-vs-Social Drinker
9.516800E-01
Non Drinker-vs-Daily Drinker
7.959200E-01
Non Drinker-vs-Weekly Drinker
5.664800E-01
Non Drinker-vs-Occasional Drinker
6.732500E-02
Non Drinker-vs-Social Drinker
5.053500E-02
Daily Drinker-vs-Weekly Drinker
7.405000E-01
Daily Drinker-vs-Occasional Drinker
1.005400E-01
Daily Drinker-vs-Social Drinker
7.491700E-02
Weekly Drinker-vs-Occasional Drinker
2.311000E-01
Weekly Drinker-vs-Social Drinker
1.647030E-01
Occasional Drinker-vs-Social Drinker
8.771000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.087500E-02
Normal-vs-Grade 2
4.597900E-02
Normal-vs-Grade 3
2.056400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.287000E-01
Grade 1-vs-Grade 3
5.078200E-01
Grade 1-vs-Grade 4
8.087500E-02
Grade 2-vs-Grade 3
2.449000E-01
Grade 2-vs-Grade 4
4.597900E-02
Grade 3-vs-Grade 4
2.056400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.389000E-01
Normal-vs-NonDiabetic
4.520600E-01
Diabetic-vs-NonDiabetic
2.200400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.545400E-01
Normal-vs-NoPancreatitis
3.968200E-01
Pancreatitis-vs-NoPancreatitis
9.752800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.099200E-01
Normal-vs-N1
4.463800E-01
N0-vs-N1
9.506000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.208200E-01
Normal-vs-TP53-NonMutant
7.287000E-01
TP53-Mutant-vs-TP53-NonMutant
6.171600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
